Delefilcon A contact lenses
DeviceSilicone hydrogel contact lenses for daily wear, daily disposable use
Other names: DAILIES TOTAL1®
NCT Number: NCT01636986
The purpose of this study was to evaluate the performance of a novel silicone hydrogel contact lens, DAILIES TOTAL1® (DT1) compared to the standard hydrogel material in 1-DAY ACUVUE® MOIST® (1DAVM) contact lens in contact lens wearers identified as having contact lens-related dryness symptoms.
Looking for future studies?
Notify Me18 year–43 year
All sexes
Interventional
Not applicable
Three study visits occurred over the course of 28 ± 3 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Silicone hydrogel contact lenses for daily wear, daily disposable use
Other names: DAILIES TOTAL1®
Hydrogel contact lenses for daily wear, daily disposable use
Other names: 1-DAY ACUVUE® MOIST™
Time frame: Day 0, Week 4
Contact lens symptoms were evaluated using the Contact Lens and Dry Eye Questionnaire (CLDEQ). The participant indicated the frequency with which 9 common contact lens-related ocular surface dryness symptoms were experienced over the previous week. Each symptom was rated on a 5-point scale (1=never, 5=constantly). Both eyes contributed to the mean. A more negative change number indicates a greater perceived improvement, namely, lessening of the symptom.
Alcon Research
Industry
Impact of a Novel Silicone Hydrogel in Reducing Contact Lens-Related Dryness Symptoms in Existing Contact Lens Wearers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01614600
Dry Eye Syndrome, Dry Eye Syndromes
View Trial DetailsNCT01482312
Dry Eye, Dry Eye Syndromes
Mississauga, Ontario, Canada
View Trial DetailsNCT03135327
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Miami, Florida, United States
View Trial DetailsNCT07087665
Eye Diseases, Myopia
Saint Louis Park, Minnesota, United States
View Trial Details